Article Text

Download PDFPDF
Cervical Spine Disease Is a Risk Factor for Persistent Phrenic Nerve Paresis Following Interscalene Nerve Block
  1. Swetha R. Pakala, MD*,
  2. James D. Beckman, MD*,
  3. Stephen Lyman, PhD and
  4. Victor M. Zayas, MD*
  1. Departments of *Anesthesiology and †Epidemiology & Biostatistics Core, Hospital for Special Surgery, New York, NY.
  1. Address correspondence to: Swetha R. Pakala, MD, Department of Anesthesiology, Hospital for Special Surgery, 535 E 70th St, New York, NY 10021 (e-mail: PakalaS{at}hss.edu).

Abstract

Abstract The use of interscalene blocks (ISBs) for shoulder surgery improves postoperative pain control, reduces recovery room times, and reduces overall hospital stays. The most common and potentially disabling adverse effect associated with ISBs is phrenic nerve paresis. Fortunately, persistent phrenic nerve paresis (PPNP) is rare. There are only 4 case reports of PPNP in the English literature. At our institution, we identified 9 cases of PPNP over a 9-year period, representing an incidence of 1 (0.048%) in 2069. In conducting a case-control series, we found that symptomatic cervical spine disease is a risk factor for the development of PPNP. Patients with PPNP had a significantly higher incidence of cervical spine disease (85.7%) compared with the control group (30.9%), P < 0.01. Persistent phrenic nerve paresis remains a perplexing complication of ISB, and many questions remain unanswered. Our data identify an important risk factor that can aid in the risk stratification of patients undergoing ISB.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Financial support was provided by the Department of Anesthesiology, Research and Education Fund, Hospital for Special Surgery.

    The authors declare no conflict of interest.